Skip to main content
. 2021 Jul 22;58(1):2004229. doi: 10.1183/13993003.04229-2020

TABLE 5.

Comparison of clinical and haemodynamic characteristics at diagnosis of pulmonary arterial hypertension (PAH) patients identified in DELPHI-2 and the index cases in their family

Index cases DELPHI-2 PAH patients p-value
Subjects 31 5
Clinical characteristics
 Female 22 (71) 4 (80) 0.90
 Age years 38 (5–63); (26–47) 50 (26–78); (41–74) 0.06
 NYHA FC
  I 0 3 <0.001
  II 4 2
  III 18 0
  IV 7 0
 6MWD m 356 (0–530); (304–400) 420 (397–533); (408–512) 0.02
Haemodynamic characteristics
 mPAP mmHg 58 (45–95); (51.5–72.3) 29 (25–50); (25.8–44.8) <0.001
 Cardiac output L·min−1 3.46 (1.85–5.9); (2.65.9–4.13) 4.05 (3.27–7.27); (3.77–5.25) 0.14
 Cardiac index L·min−1·m−2 2.10 (1.14–3.7); (1.61–2.42) 2.36 (1.94–4.38); (2.22–3.20) 0.14
 PAWP mmHg 8 (1–19); (5–9) 7 (5–8); (6.5–8) 0.6
 PVR WU 15.4 (7.6–31.8); (12.1–22.1) 7.3 (2.5–9.2); (4.0–9.2) 0.001

Data are presented as n, n (%) or median (minimum–maximum range); (interquartile range), unless otherwise stated. NYHA FC: New York Heart Association Functional Class; 6MWD: 6-min walk distance; mPAP: mean pulmonary arterial pressure; PAWP: pulmonary arterial wedge pressure; PVR: pulmonary vascular resistance.